- Report
- February 2024
- 110 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 185 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- February 2024
- 180 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- February 2024
- 172 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- February 2024
- 190 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2023
- 188 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2023
- 183 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2023
- 178 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- October 2023
- 189 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- October 2023
- 184 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- December 2023
- 150 Pages
Global
From €4087EUR$4,250USD£3,506GBP
- Report
- October 2023
- 189 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- October 2023
- 110 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- July 2023
- 119 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- January 2024
- 200 Pages
Global
From €3990EUR$4,150USD£3,423GBP
- Report
- February 2024
- 118 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 110 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 110 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- January 2024
- 110 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- October 2023
- 145 Pages
Global
From €3029EUR$3,150USD£2,598GBP
The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more